Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-Current Assets (2016 - 2025)

Lipocine's Non-Current Assets history spans 13 years, with the latest figure at $143027.0 for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 26.42% year-over-year to $143027.0; the TTM value through Sep 2025 reached $662263.0, up 12.56%, while the annual FY2024 figure was $188828.0, 35.02% up from the prior year.
  • Non-Current Assets reached $143027.0 in Q3 2025 per LPCN's latest filing, down from $157150.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $6.1 million in Q4 2021 to a low of $23753.0 in Q2 2021.
  • Average Non-Current Assets over 5 years is $1.8 million, with a median of $188828.0 recorded in 2024.
  • Peak YoY movement for Non-Current Assets: soared 25592.6% in 2021, then tumbled 96.39% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $6.1 million in 2021, then plummeted by 44.16% to $3.4 million in 2022, then tumbled by 95.9% to $139848.0 in 2023, then surged by 35.02% to $188828.0 in 2024, then decreased by 24.26% to $143027.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Non-Current Assets are $143027.0 (Q3 2025), $157150.0 (Q2 2025), and $173258.0 (Q1 2025).